Benefits Think How precision medicine fulfills fiduciary role under CAA
By steering patients to properly designed plans with the right incentives, employers can show those efforts have the best interest of health plan members in mind.
Jennifer Levin Carter, M.D.
Founder and CEO
Benefits Think Cracking the code on paying for cell and gene therapies
With breathtaking developments and opportunities around life-saving treatments come cost and coverage challenges for which advisers can prepare their clients.
Benefits Think How precision medicine can reduce the most expensive claims
Complex and rare diseases cost three to five times more than chronic conditions — a staggering employer cost that will reach trillions by 2030.
Benefits Think Precision medicine improves outcomes and lowers costs
Tailoring genetic information, environment and lifestyle factors to disease treatment and prevention holds incredible promise.